» Articles » PMID: 32691713

Angiogenesis and Blood-Brain Barrier Permeability in Vascular Remodeling After Stroke

Overview
Date 2020 Jul 22
PMID 32691713
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

Angiogenesis, the growth of new blood vessels, is a natural defense mechanism helping to restore oxygen and nutrient supply to the affected brain tissue following an ischemic stroke. By stimulating vessel growth, angiogenesis may stabilize brain perfusion, thereby promoting neuronal survival, brain plasticity, and neurologic recovery. However, therapeutic angiogenesis after stroke faces challenges: new angiogenesis-induced vessels have a higher than normal permeability, and treatment to promote angiogenesis may exacerbate outcomes in stroke patients. The development of therapies requires elucidation of the precise cellular and molecular basis of the disease. Microenvironment homeostasis of the central nervous system is essential for its normal function and is maintained by the blood-brain barrier (BBB). Tight junction proteins (TJP) form the tight junction (TJ) between vascular endothelial cells (ECs) and play a key role in regulating the BBB permeability. We demonstrated that after stroke, new angiogenesis-induced vessels in peri-infarct areas have abnormally high BBB permeability due to a lack of major TJPs in ECs. Therefore, promoting TJ formation and BBB integrity in the new vessels coupled with speedy angiogenesis will provide a promising and safer treatment strategy for improving recovery from stroke. Pericyte is a central neurovascular unite component in vascular barriergenesis and are vital to BBB integrity. We found that pericytes also play a key role in stroke-induced angiogenesis and TJ formation in the newly formed vessels. Based on these findings, in this article, we focus on regulation aspects of the BBB functions and describe cellular and molecular special features of TJ formation with an emphasis on role of pericytes in BBB integrity during angiogenesis after stroke.

Citing Articles

Regulation of BzATP-Induced Blood-Brain Barrier Endothelial Cell Hyperpermeability by NLRP3 Inflammasome Inhibition.

Anderson A, Waithe O, Seplovich G, Olagunju O, Greene C, Singh A Microcirculation. 2025; 32(3):e70006.

PMID: 40052959 PMC: 11905927. DOI: 10.1111/micc.70006.


Aging, vascular dysfunction, and the blood-brain barrier: unveiling the pathophysiology of stroke in older adults.

Alaqel S, Imran M, Khan A, Nayeem N Biogerontology. 2025; 26(2):67.

PMID: 40044939 DOI: 10.1007/s10522-025-10209-y.


bFGF-Chitosan "brain glue" promotes functional recovery after cortical ischemic stroke.

Mu J, Zou X, Bao X, Yang Z, Hao P, Duan H Bioact Mater. 2025; 46():386-405.

PMID: 39850018 PMC: 11755050. DOI: 10.1016/j.bioactmat.2024.12.017.


Bioinformatics Identification of angiogenesis-related biomarkers and therapeutic targets in cerebral ischemia-reperfusion.

Wu Y, Sun J, Huang J, Lu X Sci Rep. 2024; 14(1):32096.

PMID: 39738531 PMC: 11685884. DOI: 10.1038/s41598-024-83783-9.


Delayed Administration of IGFBP7 Improved Bone Defect Healing via ZO-1 Dependent Vessel Stabilization.

Sun S, Li Y, Li Y, Niu Y, Hu Z, Deng C Adv Sci (Weinh). 2024; 12(6):e2406965.

PMID: 39698844 PMC: 11809352. DOI: 10.1002/advs.202406965.


References
1.
Taheri S, Candelario-Jalil E, Estrada E, Rosenberg G . Spatiotemporal correlations between blood-brain barrier permeability and apparent diffusion coefficient in a rat model of ischemic stroke. PLoS One. 2009; 4(8):e6597. PMC: 2719093. DOI: 10.1371/journal.pone.0006597. View

2.
Aslanyan S, Weir C, McInnes G, Reid J, Walters M, Lees K . Statin administration prior to ischaemic stroke onset and survival: exploratory evidence from matched treatment-control study. Eur J Neurol. 2005; 12(7):493-8. DOI: 10.1111/j.1468-1331.2005.01049.x. View

3.
Burek M, Konig A, Lang M, Fiedler J, Oerter S, Roewer N . Hypoxia-Induced MicroRNA-212/132 Alter Blood-Brain Barrier Integrity Through Inhibition of Tight Junction-Associated Proteins in Human and Mouse Brain Microvascular Endothelial Cells. Transl Stroke Res. 2019; 10(6):672-683. PMC: 6842347. DOI: 10.1007/s12975-018-0683-2. View

4.
Hawkins B, Davis T . The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev. 2005; 57(2):173-85. DOI: 10.1124/pr.57.2.4. View

5.
OSullivan C, Dev K . The structure and function of the S1P1 receptor. Trends Pharmacol Sci. 2013; 34(7):401-12. DOI: 10.1016/j.tips.2013.05.002. View